Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Infadrops 100mg/ml liquid
0407010H0CEAACN
|
Infadrops | Paracetamol | Central Nervous System | No data available |
|
Inotersen 284mg/1.5ml inj pre-filled syringes
0407030AFAAAAAA
|
Inotersen | Other drugs to treat neuropathic pain | Central Nervous System | No data available |
|
Instanyl 100micrograms/dose nasal spray
0407020A0BNAHBJ
|
Instanyl | Fentanyl | Central Nervous System | No data available |
|
Instanyl 200micrograms/dose nasal spray
0407020A0BNAGBL
|
Instanyl | Fentanyl | Central Nervous System | No data available |
|
Instanyl 50micrograms/dose nasal spray
0407020A0BNAIBH
|
Instanyl | Fentanyl | Central Nervous System | No data available |
|
Integrin 10mg capsules
0402010N0BBAAAA
|
Integrin | Oxypertine | Central Nervous System | No data available |
|
Iremia 133microgram sublingual tablets
0407020A0BYAMBX
|
Iremia | Fentanyl | Central Nervous System | No data available |
|
Iremia 267microgram sublingual tablets
0407020A0BYANBZ
|
Iremia | Fentanyl | Central Nervous System | No data available |
|
Iremia 533microgram sublingual tablets
0407020A0BYAQBY
|
Iremia | Fentanyl | Central Nervous System | No data available |
|
Iremia 67microgram sublingual tablets
0407020A0BYARCH
|
Iremia | Fentanyl | Central Nervous System | No data available |
|
Iremia 800microgram sublingual tablets
0407020A0BYASBB
|
Iremia | Fentanyl | Central Nervous System | No data available |
|
Isocarboxazid 20mg/5ml oral suspension
0403020H0AAACAC
|
Isocarboxazid | Isocarboxazid | Central Nervous System | No data available |
|
Ivemend 115mg powder for solution for infusion vials
0406000AEBBAAAA
|
Ivemend | Fosaprepitant | Central Nervous System | No data available |
|
Ivemend 150mg powder for solution for infusion vials
0406000AEBBABAB
|
Ivemend | Fosaprepitant | Central Nervous System | No data available |
|
Junior Parapaed 120mg/5ml susp sugar free colour free
0407010H0CKACAW
|
Parapaed | Paracetamol | Central Nervous System | No data available |
|
Kapake 15mg/500mg tablets
0407010F0BHAFAK
|
Kapake | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | No data available |
|
Kapake 30mg/500mg effervescent tablets
0407010F0BHAEAF
|
Kapake | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | No data available |
|
Kapake Insts 30mg/500mg effervescent powder sachets
0407010F0BHABAQ
|
Kapake | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | No data available |
|
Kapake Insts 60mg/1000mg effervescent powder sachets
0407010F0BHACAR
|
Kapake | Co-codamol (Codeine phosphate/paracetamol) | Central Nervous System | No data available |
|
Kemadrin 10mg/2ml solution for injection ampoules
0409020S0BCABAC
|
Kemadrin | Procyclidine hydrochloride | Central Nervous System | No data available |
|
Kerstipon 1.5mg capsules
0411000E0BDAAAA
|
Kerstipon | Rivastigmine | Central Nervous System | No data available |
|
Kerstipon 3mg capsules
0411000E0BDABAB
|
Kerstipon | Rivastigmine | Central Nervous System | No data available |
|
Kerstipon 4.5mg capsules
0411000E0BDACAC
|
Kerstipon | Rivastigmine | Central Nervous System | No data available |
|
Kerstipon 6mg capsules
0411000E0BDADAD
|
Kerstipon | Rivastigmine | Central Nervous System | No data available |
|
Ketamine 100mg/5ml oral solution
0406000W0AAACAC
|
Ketamine hydrochloride (Nausea) | Ketamine hydrochloride | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.